Chemours (CC) Competitors $11.50 -0.48 (-4.01%) Closing price 08/1/2025 03:59 PM EasternExtended Trading$11.50 +0.01 (+0.04%) As of 08/1/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CC vs. ASIX, CE, DD, DOW, EMN, HUN, NTR, OLN, TROX, and AXTAShould you be buying Chemours stock or one of its competitors? The main competitors of Chemours include AdvanSix (ASIX), Celanese (CE), DuPont de Nemours (DD), DOW (DOW), Eastman Chemical (EMN), Huntsman (HUN), Nutrien (NTR), Olin (OLN), Tronox (TROX), and Axalta Coating Systems (AXTA). These companies are all part of the "basic materials" sector. Chemours vs. Its Competitors AdvanSix Celanese DuPont de Nemours DOW Eastman Chemical Huntsman Nutrien Olin Tronox Axalta Coating Systems Chemours (NYSE:CC) and AdvanSix (NYSE:ASIX) are both small-cap basic materials companies, but which is the superior stock? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, risk, earnings, valuation, media sentiment and analyst recommendations. Does the media prefer CC or ASIX? In the previous week, AdvanSix had 8 more articles in the media than Chemours. MarketBeat recorded 14 mentions for AdvanSix and 6 mentions for Chemours. Chemours' average media sentiment score of 0.84 beat AdvanSix's score of 0.05 indicating that Chemours is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Chemours 2 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive AdvanSix 4 Very Positive mention(s) 2 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend CC or ASIX? Chemours currently has a consensus price target of $17.44, suggesting a potential upside of 51.69%. AdvanSix has a consensus price target of $33.50, suggesting a potential upside of 74.39%. Given AdvanSix's stronger consensus rating and higher probable upside, analysts plainly believe AdvanSix is more favorable than Chemours.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Chemours 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56AdvanSix 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has preferable earnings and valuation, CC or ASIX? Chemours has higher revenue and earnings than AdvanSix. AdvanSix is trading at a lower price-to-earnings ratio than Chemours, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioChemours$5.78B0.30$86M$0.2057.50AdvanSix$1.52B0.34$44.15M$3.126.16 Is CC or ASIX a better dividend stock? Chemours pays an annual dividend of $0.35 per share and has a dividend yield of 3.0%. AdvanSix pays an annual dividend of $0.64 per share and has a dividend yield of 3.3%. Chemours pays out 175.0% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. AdvanSix pays out 20.5% of its earnings in the form of a dividend. AdvanSix has raised its dividend for 2 consecutive years. AdvanSix is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Do institutionals and insiders believe in CC or ASIX? 76.3% of Chemours shares are held by institutional investors. Comparatively, 86.4% of AdvanSix shares are held by institutional investors. 0.5% of Chemours shares are held by company insiders. Comparatively, 5.6% of AdvanSix shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is CC or ASIX more profitable? AdvanSix has a net margin of 5.45% compared to Chemours' net margin of 0.54%. Chemours' return on equity of 23.82% beat AdvanSix's return on equity.Company Net Margins Return on Equity Return on Assets Chemours0.54% 23.82% 2.07% AdvanSix 5.45%11.38%5.65% Which has more risk & volatility, CC or ASIX? Chemours has a beta of 1.61, suggesting that its share price is 61% more volatile than the S&P 500. Comparatively, AdvanSix has a beta of 1.6, suggesting that its share price is 60% more volatile than the S&P 500. SummaryAdvanSix beats Chemours on 12 of the 19 factors compared between the two stocks. Get Chemours News Delivered to You Automatically Sign up to receive the latest news and ratings for CC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CC vs. The Competition Export to ExcelMetricChemoursCHEM IndustryMaterials SectorNYSE ExchangeMarket Cap$1.79B$11.13B$3.17B$20.69BDividend Yield2.92%3.87%5.19%3.67%P/E Ratio57.5020.57117.7729.07Price / Sales0.305.1430,017,513,221,196,900.0066.37Price / Cash3.257.0623.7822.84Price / Book2.841.565.894.43Net Income$86M$507.45M$148.55M$994.22M7 Day Performance-18.81%-8.97%-3.20%-3.35%1 Month Performance-9.87%-6.62%1.47%-2.06%1 Year Performance-43.98%-4.86%28.79%10.15% Chemours Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CCChemours4.7203 of 5 stars$11.50-4.0%$17.44+51.7%-50.7%$1.79B$5.78B57.506,000Upcoming EarningsGap DownASIXAdvanSix4.1533 of 5 stars$21.970.0%$33.50+52.5%-28.2%$589.02M$1.52B7.041,450Trending NewsAnalyst DowngradeCECelanese4.6961 of 5 stars$58.00+1.2%$66.50+14.7%-64.7%$6.35B$10.28B-3.8112,163Positive NewsEx-DividendGap DownDDDuPont de Nemours4.6677 of 5 stars$76.02+0.6%$88.31+16.2%-15.5%$31.81B$12.39B-400.1124,000Positive NewsUpcoming EarningsDOWDOW4.4829 of 5 stars$28.38+0.1%$33.47+18.0%-59.1%$20.06B$42.96B70.9436,000Analyst ForecastEMNEastman Chemical4.8407 of 5 stars$77.47-0.4%$97.08+25.3%-42.2%$8.94B$9.38B9.8614,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap DownHUNHuntsman4.5235 of 5 stars$11.54+1.9%$13.17+14.1%-60.1%$2.00B$5.98B-12.686,300Trending NewsEarnings ReportDividend AnnouncementAnalyst RevisionNTRNutrien3.7214 of 5 stars$59.23-1.3%$62.78+6.0%+17.4%$28.85B$25.97B55.3525,500Trending NewsUpcoming EarningsAnalyst ForecastAnalyst RevisionOLNOlin4.2903 of 5 stars$20.49+0.5%$27.33+33.4%-59.0%$2.36B$6.54B40.177,676News CoverageEarnings ReportAnalyst ForecastGap DownTROXTronox4.7526 of 5 stars$5.46-1.2%$7.06+29.5%-78.3%$864.40M$3.07B-5.746,500News CoverageEarnings ReportInsider TradeGap DownAXTAAxalta Coating Systems4.4357 of 5 stars$29.75+0.2%$38.80+30.4%-24.1%$6.50B$5.28B14.5112,800News CoverageEarnings ReportAnalyst Forecast Related Companies and Tools Related Companies ASIX Alternatives CE Alternatives DD Alternatives DOW Alternatives EMN Alternatives HUN Alternatives NTR Alternatives OLN Alternatives TROX Alternatives AXTA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CC) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Chemours Company Please log in to your account or sign up in order to add this asset to your watchlist. Share Chemours With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.